Top

Published in:

Open Access 01-11-2012 | Meeting abstract

Market access of orphan drugs and the role of multi-criteria decision making

Author: Steven Simoens

Published in: Orphanet Journal of Rare Diseases | Special Issue 2/2012

Excerpt

A number of factors play a role in market access of orphan drugs, such as the extent to which an orphan drug meets a medical need; existence of alternative health technologies; disease prevalence; number of orphan drug indications; and added clinical benefit of the orphan drug. How can these factors be taken into account in market access decisions given that there is uncertainty over which factors matter and given that not all orphan drugs meet these criteria to the same degree [1]? …

Simoens S, Dooms M: Market access of orphan drugs: one size fits all?. Hospital Pharmacy Europe. 2012, 62: 59-63.

Title: Market access of orphan drugs and the role of multi-criteria decision making
Author: Steven Simoens
Publication date: 01-11-2012
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue Special Issue 2/2012
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/1750-1172-7-S2-A26

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Market access of orphan drugs and the role of multi-criteria decision making

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 2/2012

National plans: case study Belgium

Spina Bifida and primary prevention

How reference networks develop, implement, and monitor guidelines

From rationing to rationality: an n-of-one trial service for off-label medicines for rare (neuromuscular) diseases

Scope of centres of expertise for rare diseases in European countries where they exist

The involvement of patients in developing clinical guidelines